Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
Authors
Keywords
COVID-19, SARS-CoV-2, Inflammation, Diabetes mellitus, Adiponectin paradox, Antagonistic pleiotropy
Journal
DRUG DISCOVERY TODAY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-27
DOI
10.1016/j.drudis.2021.03.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Compounds with therapeutic potential against novel respiratory 2019 coronavirus
- (2020) Miguel Angel Martinez ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?
- (2020) Masaaki Waragai et al. Frontiers in Endocrinology
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Endocrine and metabolic link to coronavirus infection
- (2020) Stefan R. Bornstein et al. Nature Reviews Endocrinology
- Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients
- (2020) Liting Chen et al. Cellular & Molecular Immunology
- Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate
- (2020) Simon Goddek INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances
- (2020) Mahnaz Ghaebi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping
- (2020) Gagandeep Kaur et al. Journal of Inflammation-London
- ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank
- (2020) Chia-Ling Kuo et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- New-Onset Diabetes in Covid-19
- (2020) Francesco Rubino et al. NEW ENGLAND JOURNAL OF MEDICINE
- ACE2, Much More Than Just a Receptor for SARS-COV-2
- (2020) Lobelia Samavati et al. Frontiers in Cellular and Infection Microbiology
- Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
- (2020) Vibhuti Kumar Shah et al. Frontiers in Immunology
- Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis
- (2020) Laura Skrip et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers
- (2020) Anshul Jain et al. Scientific Reports
- N4-acetylcytidine is required for sustained NLRP3 inflammasome activation via HMGB1 pathway in microglia
- (2019) JuanJuan Duan et al. CELLULAR SIGNALLING
- Current and future clinical utilities of Parkinson’s Disease and dementia biomarkers: can they help us conquer the disease?
- (2019) Gilbert Ho et al. Expert Review of Neurotherapeutics
- Extracellular HMGB1 as a therapeutic target in inflammatory diseases
- (2018) Ulf Andersson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates
- (2018) Makoto Hashimoto et al. Journal of Parkinsons Disease
- Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity
- (2017) Takahiro Horiuchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vitamin D and Chronic Diseases
- (2017) Hanmin Wang et al. Aging and Disease
- Tumor necrosis factor-α impairs adiponectin signalling, mitochondrial biogenesis, and myogenesis in primary human myotubes cultures
- (2016) Tahnee Sente et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging
- (2016) Alexandra M.V. Wennberg et al. JOURNAL OF ALZHEIMERS DISEASE
- The Alarmin HMGB1 Mediates Age-Induced Neuroinflammatory Priming
- (2016) Laura K. Fonken et al. JOURNAL OF NEUROSCIENCE
- Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
- (2016) Hoon Suk Park et al. Journal of Translational Medicine
- Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
- (2016) Patrick Gavin Kehoe et al. Alzheimers Research & Therapy
- Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia
- (2015) Yan Fei Qi et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure
- (2015) Tahnee Sente et al. Journal of Cachexia Sarcopenia and Muscle
- HMGB1 in health and disease
- (2014) Rui Kang et al. MOLECULAR ASPECTS OF MEDICINE
- Adiponectin receptors: A review of their structure, function and how they work
- (2013) Toshimasa Yamauchi et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
- (2013) Albert R. Davalos et al. JOURNAL OF CELL BIOLOGY
- Up- and down-regulation of adiponectin expression and multimerization: Mechanisms and therapeutic implication
- (2012) Meilian Liu et al. BIOCHIMIE
- Decrease of miR-146b-5p in Monocytes during Obesity Is Associated with Loss of the Anti-Inflammatory but Not Insulin Signaling Action of Adiponectin
- (2012) Maarten Hulsmans et al. PLoS One
- Crosstalk in NF-κB signaling pathways
- (2011) Andrea Oeckinghaus et al. NATURE IMMUNOLOGY
- Angiotensin I-Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice
- (2010) S. M. Bindom et al. DIABETES
- Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
- (2010) M. R. Dasu et al. DIABETES CARE
- Up-regulation of Adiponectin by Resveratrol
- (2010) Anping Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential Regulation of Interleukin-1 Receptor-associated Kinase-1 (IRAK-1) and IRAK-2 by MicroRNA-146a and NF-κB in Stressed Human Astroglial Cells and in Alzheimer Disease
- (2010) Jian Guo Cui et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Anti-Inflammatory Activity of HMGB1 A Box Is Enhanced When Fused with C-Terminal Acidic Tail
- (2010) Wei Gong et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- FoxO1 Links Insulin Resistance to Proinflammatory Cytokine IL-1 Production in Macrophages
- (2009) D. Su et al. DIABETES
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Chronic infusion of angiotensin-(1–7) improves insulin resistance and hypertension induced by a high-fructose diet in rats
- (2008) Jorge F. Giani et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Adiponectin induces NF-κB activation that leads to suppression of cytokine-induced NF-κB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin
- (2008) Atsuko Tomizawa et al. Diabetes & Vascular Disease Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now